Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: September 13, 2005
Last updated: September 20, 2016
Last verified: September 2016